ERYTECH's Lead AML Drug Flunks Phase II Test Post author:Sam Post published:December 7, 2017 Post category:BioPharma The study enrolled a total of 123 patients at 30 European sites. Source: BioSpace You Might Also Like <b>Mapi Research Trust</b> Appointed As Exclusive Distributor And Mapi Language Services As Exclusive Translator Of The "Disease Activity Score (DAS-28)" July 6, 2017 AEterna Zentaris To Announce Fourth Quarter And Full-Year 2016 Financial And Operating Results On March 15, 2017 March 5, 2017 Active Implants Appoints And To Board July 11, 2017
<b>Mapi Research Trust</b> Appointed As Exclusive Distributor And Mapi Language Services As Exclusive Translator Of The "Disease Activity Score (DAS-28)" July 6, 2017
AEterna Zentaris To Announce Fourth Quarter And Full-Year 2016 Financial And Operating Results On March 15, 2017 March 5, 2017
